Outsized penalties awarded by some juries highlight risks in a longstanding strategy by drugmakers such as J&J of taking their chances at trial rather then settle product liability lawsuits brought by patients.
from Top World News- News18.com https://ift.tt/2AUKv5s
No comments:
Post a Comment